TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Guillaume Jacquot, Ph.D
Translational Research Manager at Vect-Horus

Profile

Dr. Guillaume JACQUOT has 15 years of experience in scientific project management in various fields, including cellular biology, virology, cardiovascular or neurobiology. His expertise extends to both early R&D and all the disciplines of regulatory preclinical and early clinical development. He joined VECT-HORUS in 2010 where he is responsible for the translation of early discoveries into added-value internal and collaborative projects. He also created and leads a platform dedicated to the analysis of the intracellular pharmacokinetics (ICPK) profile of targeted drug candidates.

Guillaume Jacquot, Ph.D's Network

Agenda Sessions

  • Targeted Drug Delivery to the CNS and Peripheral Tissues Using the VECTrans® Innovative Technology

    , 11:30
  • Targeted Drug Delivery to the CNS and Peripheral Tissues Using the VECTrans® Innovative Technology

    , 11:30
  • Targeted Drug Delivery to the CNS and Peripheral Tissues Using the VECTrans® Innovative Technology

    , 11:30